Keywords: medeva, reports, hepagene, results, reported, encouraging, interim

Medeva Reports On Hepagene Results

Article | 06 March 1995

Print This

Medeva has reported "encouraging" interim results from its Phase II dose ranging study of the hepatitis B vaccine candidate Hepagene ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in